Shawn J. Gagne, BA

Articles by Shawn J. Gagne, BA

Quality Measurement of Medication Monitoring in the Meaningful Use Era

ByJennifer Tjia, MD, MSCE,Terry S. Field, DSc,Shira H. Fischer, AB,Shawn J. Gagne, BA,Daniel J. Peterson, MA, MS,Lawrence D. Garber, MD,Jerry H. Gurwitz, MD

September 7th 2011

Shifting from claims to integrated electronic health records to calculate quality metrics will improve reported quality attributable to data capture changes, not true quality improvements.

Development and Pilot Testing of Guidelines to Monitor High-Risk Medications in the Ambulatory Setting

ByJennifer Tjia, MD, MSCE,Terry S. Field, DSc,Lawrence D. Garber, MD,Jennifer L. Donovan, PharmD,Abir O. Kanaan, PharmD,Marsha A. Raebel, PharmD,Yanfang Zhao, MA,Jacquelyne C. Fuller, MPH,Shawn J. Gagne, BA,Shira H. Fischer, AB,Jerry H. Gurwitz, MD

July 17th 2010

Pilot testing of guidelines for the laboratory monitoring of high-risk medications shows that monitoring is highly variable and that there is room for improvement.

Latest Updated Articles

Development and Pilot Testing of Guidelines to Monitor High-Risk Medications in the Ambulatory Setting
July 17th 2010
Quality Measurement of Medication Monitoring in the Meaningful Use Era
September 7th 2011

Shawn J. Gagne, BA

Articles by Shawn J. Gagne, BA

Quality Measurement of Medication Monitoring in the Meaningful Use Era

Development and Pilot Testing of Guidelines to Monitor High-Risk Medications in the Ambulatory Setting

Latest Updated Articles

Trending on AJMC

FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs

Fourteen Years of HIV PrEP: How New Innovations Build on Decades of Progress in HIV

Oral COVID-19 PEP May Benefit High-Risk Groups More Than General Public: Peter J. Hotez, MD

Ontada Analysis Finds GLP-1 RA Use Linked to Improved Survival in Patients With Cancer

Study Finds Flaw in Method for Key Oncology Value-Based Care Model